Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PROTAC TG2 degrader-2 (compound 7) is a selective competitive degrader of Transglutaminase 2 (TG2), exhibiting a dissociation constant (Kd) greater than 100 μM. It inhibits cell migration and reduces TG2 levels in ovarian cancer cells, making it a valuable tool for ovarian cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | PROTAC TG2 degrader-2 (compound 7) is a selective competitive degrader of Transglutaminase 2 (TG2), exhibiting a dissociation constant (Kd) greater than 100 μM. It inhibits cell migration and reduces TG2 levels in ovarian cancer cells, making it a valuable tool for ovarian cancer research [1]. |
In vitro | PROTAC TG2 degrader-2 (Compound 7) (10 μΜ, up to 24 h) inhibits migration in wound healing and invasion assays of OVCAR5 and SKOV3 cell lines [1]. Additionally, at 10 μΜ, it reduces the adherence of these cells to fibronectin [1]. When administered up to 10 μΜ for 6 h, it decreases the levels of transglutaminase 2 (TG2) in a concentration-dependent manner within 6 h in both OVCAR5 and SKOV3 cells [1]. |
Molecular Weight | 876.08 |
Formula | C47H57N9O6S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PROTAC TG2 degrader-2 PROTAC PROTACs inhibitor inhibit